Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme
Ramcharan Singh Angom(Mayo Clinic in Arizona), Debabrata Mukhopadhyay(Jacksonville College), Yash Gulani(Jacksonville College), Alfredo Quiñones‐Hinojosa(Jacksonville College), Rachel Sarabia-Estrada(Jacksonville College), Sujan Kumar Mondal(UPMC Hillman Cancer Center), Enfeng Wang(Jacksonville College), Shamit K. Dutta(WinnMed), Vijay Sagar Madamsetty(Jacksonville College), Fei Wang(Jacksonville College), Jann N. Sarkaria(Mayo Clinic in Arizona)
Cited by 36
Related Papers
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
|Neuro-Oncology|2008|387
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
|Journal of Clinical Oncology|2008|275
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
|Proceedings of the National Academy of Sciences|2011|261
In vivo gene delivery mediated by non-viral vectors for cancer therapy
|Journal of Controlled Release|2020|240
Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics
|Frontiers in Pharmacology|2019|210